Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
15.24
-0.26 (-1.68%)
At close: Nov 7, 2025, 4:00 PM EST
15.75
+0.51 (3.35%)
After-hours: Nov 7, 2025, 5:38 PM EST
Immunome Market Cap
Immunome has a market cap or net worth of $1.33 billion as of November 7, 2025. Its market cap has increased by 89.09% in one year.
Market Cap
1.33B
Enterprise Value
1.06B
1-Year Change
89.09%
Ranking
Category
Stock Price
$15.24
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $1.33B, an increase of 1,090.91%. That is a compound annual growth rate of 62.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 1.33B | 100.13% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 251.76B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |